Tag Archives: Foreign Investment Promotion Board

DIPP to send proposal to PMO on review of pharma FDI policy

Posted on June 18, 2013 by donttradeourlivesaway

Source: Economic Times June 16 2013 NEW DELHI: Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current … Continue reading →

Posted in FDI | Tagged , , , | Leave a comment

Testing the mettle of drug-makers

Posted on December 31, 2012 by donttradeourlivesaway

December 25, 2012 Hindu Business Line If there is a single defining factor in the last 12 months in the pharmaceutical industry, it has to be the attention coming back, even if just a bit, to public health. This is … Continue reading →

Posted in Compulsory Licensing, FDI, Novartis Case, Pricing, Uncategorized | Tagged , , , , | Leave a comment

FIPB nod to stay for FDI in domestic pharma units

Posted on December 9, 2012 by donttradeourlivesaway

Source: The Hindu Dec 3, 2012 The government, on Monday, decided that all foreign investments in existing domestic pharma firms should be allowed only after clearance by the Foreign Investment Promotion Board (FIPB), amid mounting concerns over availability of affordable … Continue reading →

Posted in FDI, Mergers and Acquisitions | Tagged , , | Leave a comment

Planning Commission High Level Committee overrules health ministry on 49% FDI cap in Indian generic companies

Posted on October 9, 2011 by donttradeourlivesaway

In a letter to the Indian Ministry of Health last year, Centad and other health groups had raised serious concerns about the recent acquisitions of Indian pharma companies by large foreign MNCs. Health Ministry subsequently started to work on the … Continue reading →

Posted in FDI, Mergers and Acquisitions | Tagged , | Leave a comment

Industry ministry opposes allowing brownfield investment through auto route

Posted on October 4, 2011 by donttradeourlivesaway

NEW DELHI: The Department of Industrial Policy and Promotion has raised serious doubts on the suitability of India’s competition authority to oversee acquisition of local firms by multinational drug companies. In a note of dissent addressed to the High Level … Continue reading →

Posted in Compulsory Licensing, Mergers and Acquisitions | Tagged , , , , | Leave a comment